SOFIA (Bulgaria), December 7 (SeeNews) – Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday it has acquired 3.06 million of its own shares at an average weighted price of 4.27 levs ($2.6/2.2 euro) apiece as part of its share repurchase programme.
The shares, representing a stake of 2.271% in the company, were bought back on December 6, Sopharma said in a statement.
During the trading session on December 6, a total of 4.7 million Sopharma shares changed hands on the Bulgarian Stock Exchange at an average weighted price of 4.27 per share.
On Wednesday, the company said it has bought back a total of 924,732 of its own shares in the period December 1 – December 5.
According to Dimitar Georgiev, head of trading at ELANA Trading brokerage, the intensified trading in the shares of Sopharma this week is related to the intentions of a big shareholder to reduce or sell its stake.
Currently, Sopharma holds 9.15 million of its own shares, equal to a 6.786% stake in the company.
Sopharma plans to repurchase 10% of its own shares under the buyback programme approved in June 2010.
(1 euro = 1.95583 levs)